Literature DB >> 8005209

Complete remission of metastasized adrenocortical carcinoma under o,p'-DDD.

E Kornely1, R Schlaghecke.   

Abstract

The case of a 53 year old female patient with metastasized androgen producing adrenocortical carcinoma is presented. After initial adrenalectomy a local relapse had been treated by surgery and external irradiation. Solitary liver metastases had been resected repeatedly. Subsequently multiple liver metastases required systemic chemotherapy. Treatment with o,p'-DDD (initially 12 g/d, long term treatment 1.5-3 g/d) has resulted in a complete remission for nearly 4 years. Gastrointestinal side effects occurred initially but subsided with dose reduction of o,p'-DDD.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8005209     DOI: 10.1055/s-0029-1211265

Source DB:  PubMed          Journal:  Exp Clin Endocrinol        ISSN: 0232-7384


  3 in total

Review 1.  Adrenal cortical carcinoma.

Authors:  A P Dackiw; J E Lee; R F Gagel; D B Evans
Journal:  World J Surg       Date:  2001-07       Impact factor: 3.352

2.  Sustained remission of metastatic adrenal carcinoma during long-term administration of low-dose mitotane.

Authors:  I Ilias; M Alevizaki; G Philippou; E Anastasiou; A Souvatzoglou
Journal:  J Endocrinol Invest       Date:  2001 Jul-Aug       Impact factor: 4.256

3.  Current management options for recurrent adrenocortical carcinoma.

Authors:  Anthony R Glover; Julian C Y Ip; Jing Ting Zhao; Patsy S H Soon; Bruce G Robinson; Stan B Sidhu
Journal:  Onco Targets Ther       Date:  2013-06-06       Impact factor: 4.147

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.